CLINICAL_TRIALS
trial_result
· 2021-03-16
Clinical Trial Update: Combination Therapy of Severe Aplastic Anemia [Phase 2]
Summary
Phase 2 trial update on a combination therapy for severe aplastic anemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia | Phase 2 | Status: COMPLETED